Price remains the top barrier for GLP-1 users at ~29%, but it is not the incremental driver
[13] [22] The potential risks to fetal development outweigh any benefits of weight loss during pregnancy, as weight reduction is not recommended during gestation
In contrast to the FDA-approved GLP-1 drugs, compounded drugs are typically created by licensed pharmacists for individual patient needs and are not subject to the same rigorous FDA review process for safety and efficacy
Both Wegovy and sertraline can cause side effects that may overlap or influence each other indirectly, particularly affecting gastrointestinal function and appetite
Pancreatitis with use of new diabetic medications: a real-world data study using the post-marketing FDA adverse event reporting system (FAERS) database
While Lilly and competitor Novo Nordisk struggled to meet unprecedented demand in the last few years, compounding pharmacies stepped up to fill the shortage gap, as allowed by the FDA